Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
121
121 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- C2402Not ApplicablePhase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- C2403Phase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- C52R1LPhase 31 trial
AJU Pharm Co., Ltd. · Essential Hypertension
- C52R1MPhase 31 trial
AJU Pharm Co., Ltd. · Essential Hypertension
- DWC202313Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension
- DWC202404Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Hypertension, Essential Hypertension
- DWC202405Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension
- FimasartanPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- HCP1803-4Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HGP2304-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HGP2304-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HPP2002-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HPP2003-3Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- JW0104Phase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- L606Treprostinil LiposomePhase 31 trial
Liquidia Technologies, Inc. · Pulmonary Hypertension Due to Lung Disease (Disorder)
- OPC-1085ELPhase 31 trial
Otsuka · Open Angle Glaucoma or Ocular Hypertension
- QR12000Phase 31 trial
Wuhan Createrna Science and Technology Co., Ltd · Essential Hypertension
- RLD2001-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- RLD2209-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- RLD2209-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- SYH9056Phase 31 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Mild-to-moderate Essential Hypertension
- TCA108Phase 31 trial
EMS · Hypertension
- THP-00101Forxiga Tab.Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00102Micardis Tab., THP-00103Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00104Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00105Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00106Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- QCZ484Phase 23 trials
Novartis · Hypertension (HTN), Hypertension, Hypercholesterolaemia
- QLS-111Phase 23 trials
Qlaris Bio, Inc. · Normal Tension Glaucoma (NTG), Glaucoma, Open-angle Glaucoma (OAG)
- SAL0140Phase 23 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Primary Aldosteronism, Chronic Kidney Disease, Uncontrolled Hypertension
- GW906Phase 22 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Hypertension
- HS235Phase 22 trials
35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
- LAM-001Phase 22 trials
IRulya Therapeutics Inc. · Sarcoidosis Associated Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia
- NS-863Phase 22 trials
NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension
- of QLS1410Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Hypertension (HTN), Uncontrolled Hypertension
- SYH2072Phase 22 trials
InnovStone Therapeutics Limited · Uncontrolled Hypertension, Resistant Hypertension, Primary Aldosteronism
- TonlamarsenPhase 22 trials
Kardigan, Inc. · Hypertension, Acute Severe Hypertension, Hypertensive Emergency
- TX000045Phase 22 trials
Tectonic Therapeutic · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Hypertension, Pulmonary
- AGN-193408Phase 21 trial
AbbVie · Open-angle Glaucoma, Ocular Hypertension
- APL-9796Phase 21 trial
Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension
- AR-17043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- AZD3427Phase 21 trial
AstraZeneca · Pulmonary Hypertension (World Health Organization Group 2), Heart Failure
- BEBT-701Phase 21 trial
BeBetter Med Inc · Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol
- BR1400-1Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-2Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-3Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-4Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-5Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-APhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-BPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.